Polymorphisms Implicated in Cancer Susceptibility
|
| Gene | Location | Topics
|
| ALDH2 | 12q24.2
|
-ALDH2 Polymorphisms and Cancer
|
| APC (
FPC
, DP2
, DP3
)
| 5q21-q22
|
-APC I1307K Polymorphism in Colorectal Cancer
|
| CCND1 (
D11S287E
, Cyclin D
, PRAD1
)
| 11q13
|
-CCND1 and Head and Neck Cancers
|
| CDKN2A (
P16
, INK4A
, MTS1
)
| 9p21
|
-CDKN2A Polymorphisms and Mole Density ?
|
| COMT | 22q11.2
|
-COMT Polymorphisms and Breast Cancer
|
| CYP17 | 10q24.3
|
-CYP17 and Prostate Cancer
-CYP17 and Breast Cancer
-CYP17 and Male Breast Cancer
|
| CYP19 | 15q21.1
|
-CYP19 Polymorphisms and Breast Cancer Risk
|
| CYP1A1 (
CYP1
)
| 15q22-q24
|
-CYP1A1 and Lung Cancer
-CYP1A1 and Oral Cancer
-CYP1A1 and Childhood Leukaemia
-CYP1A1 and Breast Cancer
|
| CYP1B1 (
GLC3A
)
| 2p22-p21
|
-CYP1B1 Polymorphisms in Breast Cancer
|
| CYP2A6 | 19q13.2
|
-CYP2A6 and Lung Cancer
-CYP2A6 and Nicotine Metabolism
|
| CYP2E (
CYP2E1
)
| 10q24.3-qter
|
-CYP2E and Lung Cancer
|
| GSTM1 (
GST1
, MU
)
| 1p13.3
|
-Tabacco smoke, GSTM1 and Suceptability to Lung Cancer
-GSTM1 and Bladder Cancer
-GSTM1 and Childhood Leukaemia
-GSTM1 and Breast Cancer
|
| GSTP1 (
FAEES3
, GST3
, PI
)
| 11q13
|
-GSTP1 Polymorphisms and Breast Cancer
|
| GSTT1 | 22q11.23 ?
|
-GSTT1 and Head and Neck Cancers
-GSTT1 Polymorphisms and Breast Cancer
-GSTT1 Polymorphisms and Head and Neck Cancer
|
| HRAS | 11p15.5
|
-HRAS Minisatellite Alleles and Cancer Susceptibility
-HRAS Minisatellite Alleles and Breast Cancer Risk
-HRAS Minisatellite Alleles and Ovarian Cancer Risk
-HRAS Minisatellite Alleles and Lung Cancer Risk
-HRAS Minisatellite Alleles and Colorectal Cancer Risk
|
| LTA (
TNFB
, LT
)
| 6p21.3
|
-LTA Polymorphisms and Risk of MGUS and Myeloma
|
| MC1R (
MSH-R
)
| 16q24.3
|
-MC1R Polymorphisms and Melanoma
|
| MTHFR (
NADPH
)
| 1p36.3
|
-MTHFR and Colon Cancer
-MTHFR and Acute Lymphoblastic Leukaemia
|
| MUC1 (
PUM
, PEM
)
| 1q21
|
-Defining Texts
|
| MUC6 | 11p15.5-p15.4
|
-
|
| NAT1 (
AAC1
)
| 8p23.1-p21.3
|
-NAT1 and Bladder Cancer
-NAT1 and Lung Cancer
|
| NAT2 (
AAC2
)
| 8p23.1-p21.3
|
-NAT2 and Bladder Cancer
-NAT2 and Colorectal Cancer
|
| PPP1R3 (
PP1G
)
| 7q31?
|
-PPP1R3 and Cancer
|
| SRD5A2 | 2p23
|
-SRD5A2 and Prostate Cancer
-SRD5A2 and Breast Cancer
|
| TNF (
TNFA
, TNFSF2
, DIF
)
| 6p21.3
|
-TNF Polymorphisms and Risk of MGUS and Myeloma
|
|